Relevant information on key targets and biomarkers docking. by Ying Shen (48310)

Cu ions inhibit Prs. by Javiera Norambuena (137228)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Time-dependent effects of pre-exposure to rotenone. by Joseph A. Covi (3131166)

T2D case-control analyses of up to 5,777 patients from Inter99 (n = 320), Health 2006 (n = 166), Health 2008 (n = 18), Steno Diabetes Center (n = 1,424), ADDITION (n = 1,870) and V... by Marie Neergaard Harder (232759)

Genetically altering the demand for PRPP modulates the sensitivity to Cu(II). by Javiera Norambuena (137228)

5-year persistence of innate immune responses to VZV-gE after RZV administration. Data were derived from 14 RZV recipients who received 2 doses of vaccine at Days 0 and 60. Demogra... by Michael J. Johnson (5818168)

Image5_Investigating Effect of Coherent Emission Length on Pion Interferometry in High-Energy Collisions Using a Multiphase Transport Model.EPS by Shi-Yao Wang (12521500)

“…<p>We study the two-pion Hanbury Brown–Twiss correlation functions for a partially coherent source constructed with the emission points and momenta of the identical pions generated by a multiphase transport model. …”

Growth the <i>cop</i>^- and <i>cop</i>^<i>-</i> <i>apt</i>::<i>tetM</i> strains in liquid chemically defined media with and without 30 μM Cu(II). by Javiera Norambuena (137228)

eGFR trajectories by type of physical activity. by Ronit Calderon-Margalit (584756)

“…</p><p>Results</p><p>During 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m² per year. …”

Level of stress before March 2020 and after (Willcox test). by Łukasz Kołodziej (5329022)

Analysis of MDS results. by Ying Shen (48310)

Growth with Cu(II) alters metabolite pools. by Javiera Norambuena (137228)

The optical densities of cultures of the <i>cop</i>^- and <i>cop</i>^- <i>pglS</i>::<i>Tn</i> strains were recorded after 18 hours of static growth in TSB media... by Javiera Norambuena (137228)

Concentrations of ¹³C carbon atoms in select metabolites after growth in TSB medium containing ¹³C glucose. by Javiera Norambuena (137228)

The procedure of rat PVT modeling. by Zixiang Wang (7548716)

Metabolite concentrations in the <i>cop</i>^- and <i>cop</i>^- <i>apt</i>::<i>tetM</i> strains. by Javiera Norambuena (137228)